OR WAIT null SECS
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Company News Release
Medidata Solutions
today announced that
Galderma
has standardized on the Medidata Rave® electronic data capture (EDC) and clinical data management (CDM) platform.
Based in Lausanne, Switzerland with a presence in 65 countries, Galderma operates one of the world’s largest R&D facilities dedicated exclusively to developing treatments for dermatological conditions. These state-of-the-art laboratories, located in Sophia Antipolis, France, are complemented by development centers in Princeton, New Jersey and Tokyo, Japan. With an ongoing need to conduct an expanding number of global clinical trials, Galderma’s data management team conducted an extensive, six-month evaluation of three vendors before selecting Medidata Solutions.
“Medidata’s track record executing global trials across all trial phases, coupled with their professionalism, proactivity and responsiveness, was critical to our rollout of the Rave solution,” said Francis Gon, head of Global Data Management at Galderma. “Medidata’s training and eLearning tools also made it easy for us to take the solution in-house and begin to independently build and execute studies in any phase and in multiple languages.”